Morning-Outlook-Feature-Image

NIFTY:

The NIFTY opened at 20108.50 with a gap up of just 12 points. The index initially moved sideways and eventually broke on the downside followed by a sharp intraday decline. The NIFTY opened at 20108.50 with a gap up of just 12 points. The index initially moved sideways and eventually broke on the downside followed by a sharp intraday decline. The down move found support quickly and prices moved sideways again. But this time, the index broke on the upside. Prices have seen a sharp intraday rally in the last hour of trading. In this process, the index first recorded its intraday low at 20015.85, then its intraday high at 20158.70, and finally closed at 20133.15 near its day’s high with a gain of 36.55 points or 0.18% up. All the sectoral indices have rallied and closed higher except for BANK and IT which ended with a minor loss. PHARMA and REALTY outperformed, led the bulls, and ended with a gain of over 1% followed by OIL GAS and FMCG. Support is now visible around 19850 while resistance is visible around 20200. We should look for buying only.

BANK NIFTY:

The BANK NIFTY opened at 43821.05 with a minor gap up the BANK NIFTY opened at 44711.20 with a gap up of 129 points. The index initially moved sideways and then broke on the downside after recording its intraday high at 44764.80. Prices have seen a sharp downside move and then again formed a sideways move. This time the consolidation lasted almost till the end, prices recorded its intraday low at 44254.60 and saw some recovery towards the end. The index finally closed at 44466.30 with a loss of 116 points. PSU BANK has underperformed, saw a sharp downside move, and ended with a loss of 1.10%. PVT BANK has also moved down but ended with a loss of just 0.19%. Within the index, in terms of points, AXIS BANK contributed the highest on the upside while ICICI BANK contributed the lowest. The short-term trend is up. We have been tracking support around 43800 and resistance around 44800. The index faced resistance just below 44800 and was not able to cross it higher.

TECHNICAL PICKS

COMPANY NAME CMP B/S RATIONALE
BSOFT 630.35 BUY The stock is about to give a breakout on the intraday and the daily chart. The stock can be bought above 630.35 with a stop loss of 627.45 and a target of 645.85.
FEDERAL BANK 147.35 SELL The stock has given a breakdown on the intraday as well as the daily chart. The stock can be sold below 146.65 with a stop loss of 147.80 and a target of 144.40.

DERIVATIVE PICKS

Stock Name Strike Price Buy/Sell CMP Initiation Stop Loss Target Remarks
DIVIS LAB  3800 CE BUY 115.00 CMP 97.50 166.00 BREAKOUT
Long Buildup Short Buildup
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
INDIACEM.23.11 Nov 251.55 7.75 2.86 4593600 FEDERALBNK.23.11 Nov 147.2 -1.87 17.14 26250000
GAIL.23.11 Nov 132.3 5.04 15.86 36160800 INDUSINDBK.23.11 Nov 1464.85 -1.17 6.31 7599000
ABB.23.11 Nov 4411.45 4.08 23.55 425625 SBIN.23.11 Nov 563 -1.07 7.89 29925000
BEL.23.11 Nov 145.7 3.22 19.44 26368200 ASIANPAINT.23.11 Nov 3127.25 -1 37.77 1879800
IOC.23.11 Nov 111.5 2.91 15.76 53137500 TATAMOTORS.23.11 Nov 704.6 -0.98 19.77 29286600
                                                                        Short Covering                                                                       Long Unwinding
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
IBULHSGFIN.23.11 Nov 204.3 5.42 -11.93 39795300 PNB.23.11 Nov 77.55 -2.27 -11.83 47056000
DELTACORP.23.11 Nov 140.95 4.99 -7.62 2646000 TATAPOWER.23.11 Nov 268.05 -1.87 -2.63 16888500
MUTHOOTFIN.23.11 Nov 1476.05 4.36 -14.98 739750 DLF.23.11 Nov 626.9 -1.66 -22.18 9319200
TRENT.23.11 Nov 2789.75 4.02 -16.69 776800 ADANIENT.23.11 Nov 2359.15 -1.66 -7.93 3414000
ALKEM.23.11 Nov 4712.45 3.27 -42.71 130400 RBLBANK.23.11 Nov 234.4 -1.6 -16.37 7050000

Top Delivery Percentage

Stocks Price %Chg Total Qty Delivery Del % % Change
Sectors Price Change % Quantity
Icici Prudential Life In 562.6 1.98 3217338 7527482 87.48 Nifty50 20133.15 0.18 83410897
Godrej Cons Products Ltd 1008.2 0.71 1837947 1799700 82 Niftybank 44481.75 -0.19 37645092
Marico Limited 538.65 2.21 2700338 1503886 81.77 Nifty it 32582.2 -0.08 2884245
Aditya Birla Capital Lim 168 -0.68 8992050 11055458 80.92 India Vix 12.69 -0.16 1305865372
Sbi Cards And Payment Se 739.15 0.26 2464705 1289391 80.41 Nifty Fmcg 53013.8 0.55 848009
Navin Fluorine Internati 3701.1 -0.07 109143 280265 80.33 Nifty Pharma 16238.9 1.56 103775083
Reliance Industries Ltd 2377.45 -0.97 14219992 4989032 79.63 Nifty Realty 713.6 1.44 2147483500
Gmr Airports Infrastruct 59.8 -0.83 19272526 36693488 79.3 Nifty Auto 17551.85 0.4 95679648
Itc Ltd. 435.8 -0.32 15127505 10856023 78.75 Nifty Metal 7017.45 0.01 238963073
Hindustan Unilever Ltd 2545.55 0.81 3095684 996180 78.74 Nifty Financial Services 20054.65 0.27 9597691

Upcoming Economic Data

   Domestic                                                                                                                                                  International
INR: FX Reserves, USD on 1st December, 2023

INR: Interest Rate Decision on 8th December, 2023

USD: ISM Manufacturing PMI (Nov) on 1st December, 2023

USD: Fed Chair Powell Speaks on 1st December, 2023

News Updates

  • Benchmark indices ended higher in the volatile session on November 30 with Nifty above 20,100. At close, the Sensex was up 86.53 points or 0.13 percent at 66,988.44, and the Nifty was up 36.60 points or 0.18 percent at 20,133.20. About 1838 shares advanced, 1752 shares declined, and 130 shares unchanged.

  • The Tata Technologies stock surged around 168 percent from its issue price, making it the seventh highest-listed company in India. The stock opened with a 140 percent premium and traded at Rs 1,334 on the BSE, up 168 percent from its issue price, within minutes.

  • The Defence Acquisions Council (DAC) approved the purchase of 97 Tejas Aircraft and 156 Prachanda Helicopters for a mega Rs 1.40 lakh crore deal, sources told CNBC Awaaz on November 30. Hindustan Aeronautics Limited (HAL) is the domestic supplier of Tejas and Prachanda aircraft. Sources also added that the ministry has approved Rs 1.40 lakh crore deal for the same, which includes 1 aircraft carrier.

  • Dr Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon, became a billionaire with shares of Medanta hospital chain operator Global Health Ltd rising over 100 percent this year. Currently serving as the Chairman and Managing Director of Medanta, Trehan is also the chain’s chief cardiac surgeon.

Source: Economic Times,  Indian Express, Business Today, Livemint, Business Standard, Bloomberg Quint

Board Meetings

Company Name Purpose Meeting Date Company Name Purpose Meeting Date
ASITCFIN Right Issue of Equity Shares;General 01-Dec-23 LASTMILE Issue Of Warrants;Preferential Issue of shares 04-Dec-23
ASKAUTOLTD Quarterly Results 01-Dec-23 SSLFINANCE Increase in Authorised Capital;General 04-Dec-23
EFCIL General;Preferential Issue of shares 01-Dec-23 STML Issue Of Warrants;General 04-Dec-23
IRIS Employees Stock Option Plan;Increase in Authorised Capital 01-Dec-23 SVPGLOB A.G.M. 04-Dec-23
MANINDS General 01-Dec-23 INNOVATIVE General 05-Dec-23
MANJEERA Quarterly Results 01-Dec-23 JTAPARIA General 05-Dec-23
NOVIS Quarterly Results 01-Dec-23 MODULEX Quarterly Results 05-Dec-23
QGO General 01-Dec-23 SBC Bonus issue;General 05-Dec-23
SHEETAL General;Preferential Issue of shares 01-Dec-23 SBLI Half Yearly Results;General 05-Dec-23
GENNEX Increase in Authorised Capital;Preferential Issue of shares 02-Dec-23 MPL General 06-Dec-23
MKEXIM Bonus issue;Increase in Authorised Capital;General 02-Dec-23 RMCL General;Quarterly Results 06-Dec-23
MLINDLTD Bonus issue;General 02-Dec-23 DOLPHINOFF Stock  Split 07-Dec-23
PGCRL General;Preferential Issue of shares 02-Dec-23 KEYFINSER Reduction of Capital 08-Dec-23
SADHNANIQ Right Issue of Equity Shares 02-Dec-23 RNAVAL General;Quarterly Results 08-Dec-23
TRIVENIENT Increase in Authorised Capital;General 02-Dec-23 WARDINMOBI General 08-Dec-23
ATHENAGLO Issue Of Warrants 04-Dec-23 EMMESSA Quarterly Results 09-Dec-23
BASML General 04-Dec-23 GROWINGTON General;Stock  Split 13-Dec-23
GANGAPHARM Issue Of Warrants;Preferential Issue of shares 04-Dec-23 AKSHAR Buy Back of Shares;Bonus issue;Interim Dividend 15-Dec-23
HINDBIO General 04-Dec-23 METALFORGE Quarterly Results 15-Dec-23

Corporate Action

Company Name Ex-Date Purpose Company Name Ex-Date Purpose
ALPHAIND 01-Dec-23 Bonus issue 1:1 STEELXIND 11-Dec-23 E.G.M.
NITINCAST 01-Dec-23 E.G.M. BPCL 12-Dec-23 Interim Dividend – Rs. – 21.0000
JYOTISTRUC 04-Dec-23 E.G.M. RHL 12-Dec-23 E.G.M.
PANCHSHEEL 04-Dec-23 Interim Dividend – Rs. – 0.8000 RCF 13-Dec-23 Final Dividend – Rs. – 3.7000
BOROLTD 05-Dec-23 Spin Off FORINTL 14-Dec-23 E.G.M.
SCL 06-Dec-23 E.G.M. FRANKLININD 21-Dec-23 E.G.M.
DHYAANI 07-Dec-23 Bonus issue 9:5 KLRFM 22-Dec-23 Dividend – Rs. – 2.0000
POOJAENT 08-Dec-23 Bonus issue 6:1 RAWEDGE 22-Dec-23 E.G.M.

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and

(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.

For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale.

Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

  1. Reports
  2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;

(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

  1. Compensation

(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;

(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;

(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(d) EWL  or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.

3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL

Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.